Monday, September 30, 2024
HomeNews

News

Molecure to Regain Worldwide Rights to Dual Chitinase Inhibitor OATD-01

Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug...

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced that the Company presented new preclinical data demonstrating the...

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that the Italian Medicines Agency, or Agenzia Italiana del...

Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central

Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a...
0FansLike
0FollowersFollow
spot_img

Hot Topics